Učitavanje...

Timing of dornase alfa inhalation for cystic fibrosis

BACKGROUND: Inhalation of the enzyme dornase alfa reduces sputum viscosity and improves clinical outcomes of people with cystic fibrosis. This is an update of a previously published Cochrane review. OBJECTIVES: To determine the effect of timing of dornase alfa inhalation on measures of clinical effi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cochrane Database Syst Rev
Glavni autori: Dentice, Ruth, Elkins, Mark
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2016
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6474180/
https://ncbi.nlm.nih.gov/pubmed/27457496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007923.pub4
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!